Stifel Financial
TXG icon

Stifel Financial’s 10x Genomics TXG Stock Holding History

Stifel Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
39,056
-4,730
-11% -$124K ﹤0.01% 2298
2026
Q1 		$930K Sell
43,786
-138,838
-76% -$2.78M ﹤0.01% 2492
2025
Q4 		$2.98M Sell
182,624
-9,714
-5% -$147K ﹤0.01% 1647
2025
Q3 		$2.25M Buy
192,338
+165,903
+628% +$2.16M ﹤0.01% 1828
2025
Q2 		$306K Buy
26,435
+2,725
+11% +$24.8K ﹤0.01% 3040
2025
Q1 		$207K Buy
23,710
+2,713
+13% +$34.2K ﹤0.01% 3175
2024
Q4 		$302K Buy
20,997
+4,628
+28% +$73K ﹤0.01% 2959
2024
Q3 		$370K Buy
16,369
+5,890
+56% +$122K ﹤0.01% 2851
2024
Q2 		$204K Buy
10,479
+2,479
+31% +$64.9K ﹤0.01% 3109
2024
Q1 		$300K Buy
8,000
+2,066
+35% +$90.8K ﹤0.01% 2910
2023
Q4 		$332K Buy
+5,934
New +$258K ﹤0.01% 2790
2023
Q3 		– Sell
-4,733
Closed -$264K – 3406
2023
Q2 		$264K Buy
4,733
+73
+2% +$3.95K ﹤0.01% 2905
2023
Q1 		$260K Sell
4,660
-16,868
-78% -$788K ﹤0.01% 2904
2022
Q4 		$784K Buy
21,528
+3,996
+23% +$131K ﹤0.01% 2179
2022
Q3 		$499K Sell
17,532
-5,329
-23% -$203K ﹤0.01% 2434
2022
Q2 		$1.03M Buy
22,861
+821
+4% +$42.6K ﹤0.01% 1967
2022
Q1 		$1.68M Buy
22,040
+3,927
+22% +$344K ﹤0.01% 1742
2021
Q4 		$2.7M Buy
18,113
+13,409
+285% +$2.05M ﹤0.01% 1414
2021
Q3 		$685K Sell
4,704
-287
-6% -$49.3K ﹤0.01% 2377
2021
Q2 		$978K Sell
4,991
-7,691
-61% -$1.39M ﹤0.01% 2120
2021
Q1 		$2.3M Buy
12,682
+5,755
+83% +$994K ﹤0.01% 1437
2020
Q4 		$981K Buy
+6,927
New +$1.01M ﹤0.01% 1857
2020
Q1 		– Sell
-2,709
Closed -$207K – 3082
2019
Q4 		$207K Buy
+2,709
New +$163K ﹤0.01% 2748

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stifel Financial's TXG Position: Q2 2026 in Review

Stifel Financial reduced its 10x Genomics (TXG) stake by 11% in Q2 2026, selling an estimated $124K and leaving 39,056 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Stifel Financial first reported a position in TXG in Q4 2019 and has held it in 23 quarters since. The position peaked at $2.98M in Q4 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Stifel Financial held 39,056 shares of 10x Genomics worth $1.5M as of Q2 2026.
  • Stifel Financial sold 4,730 10x Genomics shares in Q2 2026, an estimated $124K.
  • 10x Genomics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2298 holding.
  • Stifel Financial first reported a position in 10x Genomics in Q4 2019 and has held it in 23 quarters since.
  • Stifel Financial's 10x Genomics position peaked at $2.98M in Q4 2025.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.